-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Nutex Health, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2017 to Q1 2025.
- Nutex Health, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2025 was -$2.5M, a 2532% decline year-over-year.
- Nutex Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2024 was -$13.1M, a 130% decline from 2023.
- Nutex Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$5.71M, a 214% decline from 2022.
- Nutex Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $5M.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)